Gene Therapy Guidance Urges 15-Year Follow-Up, With Five "Close" Years
Executive Summary
FDA's draft guidance on gene therapy studies follows the recommendations of the Biological Response Modifiers Advisory Committee in calling for 15 years of follow-up for patients